Concepedia

Faezeh Darbaniyan

FD

6

Publications

213

Citations

6

H-Index

2021

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Moffitt Cancer Center

Cornell University

Faezeh Darbaniyan is an author at The University of Texas MD Anderson Cancer Center specializing in hematology, medicine, and oncology.

Top concepts

Publications per year

2021–2024

6

Publications

6

Azacitidine plus venetoclax in patients with high-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: phase 1 results of a single-centre, dose-escalation, dose-expansion, phase 1–2 study

Alexandre Bazinet, Faezeh Darbaniyan, Elias Jabbour et al. · The Lancet Haematology · 2022 · 79 citations

, , +7

Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy

Rishika Prasad, Abdur Rehman, Lubna Rehman et al. · Blood · 2024 · 39 citations · Full text

Low-Dose Decitabine versus Low-Dose Azacitidine in Lower-Risk MDS

Koji Sasaki, Elias Jabbour, Guillermo Montalban‐Bravo et al. · NEJM Evidence · 2022 · 38 citations

Only <i>SF3B1</i> mutation involving K700E independently predicts overall survival in myelodysplastic syndromes

Rashmi Kanagal‐Shamanna, Guillermo Montalban‐Bravo, Koji Sasaki et al. · Cancer · 2021 · 30 citations · Full text

Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group

Rashmi Kanagal‐Shamanna, Attilio Orazi, Robert P. Hasserjian et al. · Modern Pathology · 2021 · 16 citations · Full text

, , +11

Rows per page

1–5 of 6